(Q34471681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Clinically relevant therapeutic endpoints in type I Gaucher disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

C E Hollak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Maas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

Journal of Inherited Metabolic Disease

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

24 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

97-105; discussion 87-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11758685%20AND%20SRC:MED&resulttype=core&format=json

Gaucher's disease: clinical features and natural history

5 December 2019

cites work

1 reference

12 December 2020

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease

1 reference

12 December 2020

1 reference

12 December 2020

Quality of life assessment in adults with type 1 Gaucher disease.

1 reference

12 December 2020

Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease

1 reference

12 December 2020

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

1 reference

12 December 2020

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

1 reference

12 December 2020

Gaucher disease: recommendations on diagnosis, evaluation, and monitoring

1 reference

12 December 2020

Analysis of the lipids of normal and Gaucher bone marrow.

1 reference

12 December 2020

A less costly regimen of alglucerase to treat Gaucher's disease.

1 reference

12 December 2020

Current issues in enzyme therapy for Gaucher disease

1 reference

12 December 2020

Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement

1 reference

12 December 2020

The human chitotriosidase gene. Nature of inherited enzyme deficiency

1 reference

12 December 2020

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease

1 reference

12 December 2020

Accelerated skeletal deterioration after splenectomy in Gaucher type 1 disease

1 reference

12 December 2020

Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase

1 reference

12 December 2020

Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development.

1 reference

12 December 2020

Risk factors for osteonecrosis in patients with type 1 Gaucher's disease

1 reference

12 December 2020

Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy.

1 reference

12 December 2020

Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease

1 reference

12 December 2020

Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease

1 reference

12 December 2020

Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment

1 reference

12 December 2020

The clinical course of treated and untreated Gaucher disease. A study of 45 patients

1 reference

12 December 2020

Individualised low-dose alglucerase therapy for type 1 Gaucher's disease

1 reference

12 December 2020

Plasma and metabolic abnormalities in Gaucher's disease.

1 reference

12 December 2020

Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months

1 reference

12 December 2020